Hicks CW , Selvarajah S & Mathioudakis N et al.: Burden of infected diabetic foot ulcers on hospital admissions and costs. Ann Vasc Surg 33: 149, 2016.
Schreml S , Szeimies RM & Prantl L et al.: Oxygen in acute and chronic wound healing. Br J Dermatol 163: 257, 2010.
Hunt TK , Ellison EC & Sen CK: Oxygen: at the foundation of wound healing: introduction. World J Surg 28: 291, 2004.
Knighton DR , Silver IA & Hunt TK: Regulation of wound-healing angiogenesis-effect of oxygen gradients and inspired oxygen concentration. Surgery 90: 262, 1981.
Pai MP & Hunt TK: Effect of varying oxygen tensions on healing of open wounds. Surg Gynecol Obstet 135: 756, 1972.
Sibbald GR , Woo KY & Queen D: Wound bed preparation and oxygen balance: a new component? Int Wound J 4 (suppl 3): 9, 2007.
Rodriguez PG , Felix FN & Woodley DT et al.: The role of oxygen in wound healing: a review of the literature. Dermatol Surg 34: 1159, 2008.
Arenberger P , Engels P & Arenbergerova M et al.: Clinical results of the application of a hemoglobin spray to promote healing of chronic wounds. GMS Krankenhhyg Interdiszip 6: Doc05, 2011.
Petri M , Stoffels I & Griewank K et al.: Oxygenation status in chronic leg ulcer after topical hemoglobin application may act as a surrogate marker to find the best treatment strategy and to avoid ineffective conservative long-term therapy. Molec Imag Biol 20: 124, 2018.
Dissemond J , Kröger K & Storck M et al.: Topical oxygen wound therapies for chronic wounds: a review. J Wound Care 24: 53, 2015.
Hunt S & Elg F: The clinical effectiveness of haemoglobin spray as an adjunctive therapy in the treatment of chronic wounds. J Wound Care 26: 1, 2017.
Gottrup F , Dissemond J & Baines C et al.: Use of oxygen therapies in wound healing, with special focus on topical and hyperbaric oxygen treatment. J Wound Care 26 (suppl 5): S1, 2017.
Chadwick P , McCArdle J & Mohamud L et al.: Appropriate use of topical haemoglobin in chronic wound management: consensus recommendations. Diabetic Foot J 18: 142, 2015.
Hon J , Lagden K & McLaren AM et al.: A prospective, multicenter study to validate use of the PUSH in patients with diabetic, venous, and pressure ulcers. Ostomy Wound Manage 56: 26, 2010.
Augustin M , Conde Montero E & Zander N et al.: Validity and feasibility of the wound QoL questionnaire on health related quality of life in chronic wounds. Wound Repair Regen 25: 852, 2017.
Goodridge D , Trepman E & Sloan J et al.: Quality of life of adults with unhealed and healed diabetic foot ulcers. Foot Ankle Int 27: 274, 2006.
Ince P , Abbas Z & Lutale J et al.: Use of the SINBAD classification system and score in comparing outcome of foot ulcer management in three continents. Diabetes Care 31: 9647, 2008.
De Smet GHJ , Kroese LF & Menon AG et al.: Oxygen therapies and their effects on wound healing. Wound Rep Regen 25: 591, 2017.
Margolis DJ , Kantor J & Berlin JA: Healing of diabetic neuropathic foot ulcers receiving standard treatment: a meta-analysis. Diabetes Care 22: 692, 1999.
Sheehan P , Jones P & Caselli A et al.: Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Diabetes Care 26: 1879, 2003.
Stang D , Young M & Wilson D et al.: The role of topical oxygen therapy in the management of diabetic foot ulcer wounds in Scotland: round table recommendations. Diabet Foot J 21: 56, 2018.
Arenbergerova M , Engels P & Gkalpakiotis S et al.: Effect of topical haemoglobin on venous leg ulcers healing. EWMA J 13: 25, 2013.
Hunt SD: Topical oxygen-haemoglobin use on sloughy wounds: positive patient outcomes and the promotion of self-care. Wounds UK 11: 90, 2015.
Haycocks S , McCardle J & Findlow AH et al.: Evaluating the effect of a haemoglobin spray on size reduction in chronic DFUs. Br J Nurs 25: S54, 2016.
Ioannidis JP: Why most clinical research is not useful. PLoS Med 13: e1002049, 2016.
Achieving timely healing of foot ulcers can help avoid complications such as infection and amputation; topical oxygen therapy has shown promise in achieving this. We evaluated the clinical effectiveness of Granulox, a hemoglobin spray device designed to deliver oxygen to the surface of wounds, for the healing of foot ulcers.
We conducted a single-center, prospective, randomized controlled trial comparing standard of care (once-weekly podiatric medical clinic visits) versus standard care plus adjunct Granulox therapy twice weekly in adults with foot ulcers. After a 2-week screening phase, patients in whom the index wound had healed by less than 50% were randomized 1:1. Outcome measures were collated during the trial phase at 6 and 12 weeks.
Of 79 patients enrolled, 38 were randomized. After 12 weeks, the median percentage wound size reduction compared with the size of the ulcer at the start of the trial phase was 100% for the control arm and 48% for the Granulox arm (P = .21, Mann-Whitney U test). In the former, eight of 14 foot ulcers had healed; in the latter, four of 15 (P = .14, Fisher exact test). In the control arm, two amputations and one withdrawal occurred, whereas in the Granulox arm, one unrelated death and five withdrawals were recorded.
We could not replicate the favorable healing associated with use of Granulox as published by others. Differences in wound chronicity and frequency of Granulox application might have influenced differences in study results. Granulox might perform best when used as an adjunct for treatment of chronic wounds at least 8 weeks old.
Department of Research and Development, Carleton Clinic, North Cumbria Integrated Care NHS, Carlisle, United Kingdom.
Department of Podiatry, Carleton Clinic, North Cumbria Integrated Care NHS, Carlisle, United Kingdom.
Conflict of interest: None reported.